BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33470349)

  • 1. Probing for congenital nasolacrimal duct obstruction: a systematic review and meta-analysis of randomized clinical trials.
    Farat JG; Schellini SA; Dib RE; Santos FGD; Meneghim RLFS; Jorge EC
    Arq Bras Oftalmol; 2021; 84(1):91-98. PubMed ID: 33470349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing for congenital nasolacrimal duct obstruction.
    Petris C; Liu D
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011109. PubMed ID: 28700811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocanalicular silastic intubation for the initial correction of congenital nasolacrimal duct obstruction.
    Engel JM; Hichie-Schmidt C; Khammar A; Ostfeld BM; Vyas A; Ticho BH
    J AAPOS; 2007 Apr; 11(2):183-6. PubMed ID: 17307001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Endoscopically Assisted Primary Probing and Bicanalicular Silicone Intubation for Congenital Nasolacrimal Duct Obstruction in Children Aged 4 to 7 Years.
    Arici C; Mergen B; Ozan T; Batu Oto B
    J Pediatr Ophthalmol Strabismus; 2023; 60(2):101-107. PubMed ID: 35446188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of treatment for congenital nasolacrimal duct obstruction: a systematic review and meta-analysis.
    Lin AE; Chang YC; Lin MY; Tam KW; Shen YD
    Can J Ophthalmol; 2016 Feb; 51(1):34-40. PubMed ID: 26874157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review of endoscopic-assisted surgical management for congenital nasolacrimal duct obstruction.
    Trott S; Colgrove N; Westgate P; Bush M; Iverson K
    Int J Pediatr Otorhinolaryngol; 2020 Dec; 139():110448. PubMed ID: 33091808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights in the treatment of congenital nasolacrimal duct obstruction.
    Avram E
    Rom J Ophthalmol; 2017; 61(2):101-106. PubMed ID: 29450381
    [No Abstract]   [Full Text] [Related]  

  • 8. Stepwise treatment paradigm for congenital nasolacrimal duct obstruction.
    Casady DR; Meyer DR; Simon JW; Stasior GO; Zobal-Ratner JL
    Ophthalmic Plast Reconstr Surg; 2006; 22(4):243-7. PubMed ID: 16855492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic-assisted retrieval of retained lacrimal stent material in congenital nasolacrimal duct obstruction without dacryocystorhinostomy.
    Ng DS; Chan E; Tong FM; Chow SK; Ko ST
    Orbit; 2016; 35(2):103-5. PubMed ID: 26838355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocanalicular intubation with Monoka tubes for the treatment of congenital nasolacrimal duct obstruction.
    Kaufman LM; Guay-Bhatia LA
    Ophthalmology; 1998 Feb; 105(2):336-41. PubMed ID: 9479296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of congenital nasolacrimal duct obstruction--latin american study.
    Schellini SA; Ariki CT; Sousa RL; Weil D; Padovani CR
    Ophthalmic Plast Reconstr Surg; 2013; 29(5):389-92. PubMed ID: 23924988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preloaded Monoka (Lacrijet) and congenital nasolacrimal duct obstruction: Initial results.
    Fayet B; Racy E; Ruban JM; Katowitz JA; Katowitz WR; Brémond-Gignac D
    J Fr Ophtalmol; 2021 May; 44(5):670-679. PubMed ID: 33836913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of treatment modalities and prognostic factors in children with congenital nasolacrimal duct obstruction.
    Al-Faky YH; Al-Sobaie N; Mousa A; Al-Odan H; Al-Huthail R; Osman E; Al-Mosallam AR
    J AAPOS; 2012 Feb; 16(1):53-7. PubMed ID: 22370666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, randomised comparison of probing versus bicanalicular silastic intubation for congenital nasolacrimal duct obstruction.
    Al-Faky YH; Mousa A; Kalantan H; Al-Otaibi A; Alodan H; Alsuhaibani AH
    Br J Ophthalmol; 2015 Feb; 99(2):246-50. PubMed ID: 25185252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silastic intubation in congenital nasolacrimal duct obstruction: a study of 129 eyes.
    al-Hussain H; Nasr AM
    Ophthalmic Plast Reconstr Surg; 1993; 9(1):32-7. PubMed ID: 8443112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Success rates of probing for congenital nasolacrimal duct obstruction at various ages.
    Świerczyńska M; Tobiczyk E; Rodak P; Barchanowska D; Filipek E
    BMC Ophthalmol; 2020 Oct; 20(1):403. PubMed ID: 33032542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of balloon catheter dilatation and silicon intubation as the secondary treatment for congenital nasolacrimal duct obstruction after failed primary probing].
    Hu M; Wu Q; Fan YW; Cao WW; Lin Q; Yu G
    Zhonghua Yan Ke Za Zhi; 2016 Feb; 52(2):123-8. PubMed ID: 26906708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Premature Tube Extrusion for Simple Congenital Nasolacrimal Duct Obstruction: A Comparison of Monocanalicular and Bicanalicular Intubation.
    Dryden SC; Meador AG; Awh C; Smith BD; Eder AE; Bohn SN; Hoehn ME; Fowler B; Fleming JC
    J Craniofac Surg; 2022 Jan-Feb 01; 33(1):211-213. PubMed ID: 34292239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical mitomycin in endoscopic-assisted probing for the treatment of congenital nasolacrimal duct obstruction in older children.
    Galindo-Ferreiro A; Khandekar R; Akaishi PM; Cruz AAV; Galvez-Ruiz A; Dolmetsch A; Schellini SA
    Arq Bras Oftalmol; 2020 Jun; 83(3):229-235. PubMed ID: 32490970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting the success of nasolacrimal duct probing for congenital nasolacrimal duct obstruction.
    Mannor GE; Rose GE; Frimpong-Ansah K; Ezra E
    Am J Ophthalmol; 1999 May; 127(5):616-7. PubMed ID: 10334364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.